X @Forbes
Forbes·2025-12-12 17:45
A report stating that the Trump administration is close to reclassifying cannabis as a Schedule III drug—on par with mild painkillers—has the $32 billion industry hotly anticipating reform.Read more: https://t.co/cU5i6hGc0DPhoto: Jens Schlueter/AFP via Getty Images https://t.co/iY80nS13ak ...